Antiviral and antitumor compounds from tunicates. 1983

K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren

Tunicates provide a rich source of biologically active compounds with potentially useful medicinal properties. The most interesting compounds identified thus far are the didemnins, depsipeptides from a Caribbean Trididemnum species, which are potent inhibitors of L1210 leukemia cells in vitro and are also active in vivo against P388 leukemia and B16 melanoma. In addition the didemnins inhibit growth of a variety of RNA and DNA viruses in vitro and protect mice infected intravaginally with herpes simplex virus type 2. Didemnin B, a derivative of didemnin A, is far more active than A, which argues for the likelihood of further useful chemical modifications in the series.

UI MeSH Term Description Entries
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000828 Animal Population Groups Animals grouped according to ecological, morphological or genetic populations. Animal Population Group,Population Group, Animal,Population Groups, Animal
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014561 Urochordata A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians. Ascidia,Tunicata,Ascidiacea,Ascidians,Sea Squirts,Tunicates,Urochordates,Ascidian,Sea Squirt,Squirt, Sea,Tunicate,Urochordate
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D047630 Depsipeptides Compounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized. Cyclic Depsipeptide,Cyclodepsipeptide,Depsipeptide,Peptolide,Peptolides,Cryptophycins,Cyclodepsipeptides,Depsipeptides, Cyclic,Cyclic Depsipeptides,Depsipeptide, Cyclic

Related Publications

K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
January 2000, Medicinal research reviews,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
January 2022, Anti-cancer agents in medicinal chemistry,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
January 1974, Topics in current chemistry,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
January 1989, Advances in applied microbiology,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
October 2002, Proceedings of the National Academy of Sciences of the United States of America,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
July 2018, Microorganisms,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
December 2020, Postepy biochemii,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
June 2009, Marine drugs,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
July 1966, The Journal of antibiotics,
K L Rinehart, and J B Gloer, and G R Wilson, and R G Hughes, and L H Li, and H E Renis, and J P McGovren
February 2013, Journal of natural products,
Copied contents to your clipboard!